Floatz logo

ALMURTIDE

GIST

Robert WesolowskiSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the GIST cohort.

Asset / SponsorPhaseRating
Regorafenib
Institut Bergonié
Phase 4BBB
Avapritinib
Blueprint Medicines Corporation
Phase 3BB
Tas-102
AEterna Zentaris
Phase 1CC
Perifosine
AEterna Zentaris
Phase 1CC
Her-2 Vaccine
Robert Wesolowski
Phase 1CC

View all 9 →

Same molecule, other indications

ALMURTIDE is also rated in:

Malignant Solid TumourDormant
CC
Indicative ·
47 / 100
View asset →
Malignant Tumor of ColonDormant
CC
Indicative ·
47 / 100
View asset →
Breast CancerDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →